ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,290Medicare Part D Prescriptions Filled, Including Refills

Rank: 496 out of 5176

$751K Total Retail Price of All Prescriptions

Rank: 537 out of 5176

700 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 700 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 700 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,937 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 833 733 1 1
AMLODIPINE BESYLATE 481 444 2 2
METFORMIN HCL 427 362 3 7
FUROSEMIDE 328 294 4 8
OMEPRAZOLE 318 248 5 3
AMLODIPINE BESYLATE-BENAZEPRIL 288 244 6 55
METOPROLOL SUCCINATE 264 237 7 11
LEVOTHYROXINE SODIUM 227 199 8 4
METOPROLOL TARTRATE 226 200 9 6
GLIMEPIRIDE 200 189 10 37
ATENOLOL 176 171 11 12
HYDROCHLOROTHIAZIDE 173 161 12 10
ZOLPIDEM TARTRATE 168 148 13 17
ATORVASTATIN CALCIUM 168 144 13 9
LISINOPRIL 163 154 15 5
WARFARIN SODIUM 148 144 16 13
METFORMIN HCL ER 146 126 17 57
RANITIDINE HCL 139 136 18 36
LOVASTATIN 139 136 18 46
DIOVAN 133 124 20 19
ENALAPRIL MALEATE 126 83 21 22
TAMSULOSIN HCL 124 116 22 20
TRIAMTERENE-HCTZ 110 109 23 86
DIOVAN HCT 110 104 23 39
ADVAIR DISKUS 98 68 25 32
CLOPIDOGREL 97 83 26 26
ACTOS 96 62 27 85
ALENDRONATE SODIUM 95 74 28 18
PLAVIX 94 93 29 29
CRESTOR 91 68 30 15
SINGLE USE SWAB 87 66 31 108
QUINAPRIL HCL 83 80 32 82
SYNTHROID 78 70 33 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 70 33 49
IBUPROFEN 77 56 35 72
ALLOPURINOL 76 70 36 41
LOSARTAN POTASSIUM 75 65 37 14
JANUVIA 69 69 38 25
ACTONEL 66 65 39 134
TRAMADOL HCL 65 63 40 40
NEXIUM 64 53 41 16
PEN NEEDLE 61 52 42 144
BYSTOLIC 61 61 42 96
LANTUS 60 59 44 66
LANTUS SOLOSTAR 58 46 45 70
RAMIPRIL 58 49 45 50
GLIPIZIDE ER 57 57 47 117
ISOSORBIDE MONONITRATE ER 56 53 48 44
LOSARTAN-HYDROCHLOROTHIAZIDE 56 52 48 35
MECLIZINE HCL 55 47 50 81
GABAPENTIN 55 50 50 21
LOVAZA 54 54 52 43
DILTIAZEM 24HR ER 54 54 52 136
PROPRANOLOL HCL 51 41 54 199
LEVOXYL 50 46 55 238
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.